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INTRODUCTION
      The National Atomic Energy Commission of 
Argentina (CNEA) has constructed a thermal neutron 
source for use in Boron Neutron Capture Therapy 
(BNCT) applications at the RA-3 research reactor 
facility located in Buenos Aires. The Idaho National 
Laboratory (INL) and CNEA have jointly conducted 
some initial neutronic characterization measurements 
for this source.
     The RA-3 reactor (Figure 1) is of the open pool 
type, with 20% enriched uranium plate fuel and light 
water coolant. A graphite thermal column is situated 
on one side of the reactor as shown.  A tunnel 
penetrating the graphite structure enables the 
insertion of samples while the reactor is in normal 
operation.  Samples up to 14 cm height and 15 cm 
width are accommodated. 
Figure 1.   RA-3 reactor and thermal column. 
METHODS AND MATERIALS 
     RA-3 is being considered for small-animal 
radiobiological studies, at first using an animal model 
based on induced tumors of the oral mucosa in the 
hamster cheek pouch [1, 2].  Shielding of the body of 
the animal from the thermal neutron flux while 
exposing the everted cheek pouch is accomplished 
using an enclosure fabricated from plates composed 
of a 6 mm layer of lithium carbonate enriched to 95% 
in lithium-6 sealed between thin sheets of LuciteTM
(Figure 2).  A Lucite phantom of the shape and size 
of a typical Syrian hamster is shown in position in 
the shield enclosure. With an actual animal, the 
cheek pouch is everted onto the protruding shelf on 
one end of the shield, which is placed in the 
irradiation cavity with the pouch shelf on the 
upstream side. 
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Figure 2.  Thermal neutron shielding enclosure with 
hamster phantom. 
     Measurements of the neutron flux at the 
irradiation location were performed using simplified 
extensions of neutron activation techniques [3] that 
have been adapted for BNCT applications by the 
INL.  All irradiations were conducted at a reactor 
power of 8 MW.  
     The free-field neutron flux spectrum at the 
irradiation location, without the shield enclosure, was 
characterized using foils composed of:  1) bare gold, 
2) gold, indium, tungsten, manganese and copper 
enclosed in cadmium and, 3) indium enclosed in 
boron-10.  This provided 7 linearly-independent 
spectral response functions covering the energy range 
from thermal to about 1 MeV.    
     Measurements to determine the spatial distribution 
of the thermal and above-thermal neutron flux at 12 
locations on the surface of, and within, the hamster 
phantom and at three locations on the pouch shelf 
were based on activation of copper-gold flux wires 
approximately 7 mm in length and 1 mm in diameter. 
Each wire had a mass of approximately 70 mg and 
was composed of copper alloyed with 1.55 percent 
gold by weight.  This provided two linearly-
independent activation responses (neutron capture in 
Cu-63 and Au-197).    
RESULTS
     The measured activities were used to unfold  2-
group neutron spectra using an overdetermined least-
square fitting method [3] with effective cross sections 
for the foils and wires computed using the MCNP [4] 
code with a graphite moderated fission source 
spectrum.   With the foils this procedure yielded a 
free-field thermal flux of 7.1x109 n/cm2-s and a fast 
flux of 2.5x106 n/cm2-s, with estimated uncertainties 
of approximately 6% (1?).  The cadmium ratio for 
the gold foils was approximately 4100, indicating a 
very well-thermalized neutron field, with negligible 
radiation dose component from hydrogen recoil in 
tissue.
     In the case of the phantom, the thermal neutron 
flux at the outermost position on the pouch shelf was 
5.4x109 n/cm2-s, with an uncertainty of 
approximately 8%.    This is about 25% lower than is 
the case for the free-field flux at this location, and is 
largely due to local flux depression by the shield 
enclosure.  The wire measurements also show that 
the thermal neutron flux at all locations within the 
shield container is at least a factor of 20 lower than 
the flux on the shelf.   This implies that the boron 
dose to the whole body will be correspondingly 
smaller relative to the dose in the target tissue, 
conservatively assuming the same boron 
concentration in all tissues. 
DISCUSSION
     RA-3 should be a useful irradiation facility for 
BNCT-related small-animal studies.   The fast-
neutron dose will be insignificant compared to the 
thermal-neutron induced boron neutron capture dose 
in the presence of clinically-relevant (~30 ppm) 
quantities of 10B.  The absolute thermal flux 
magnitude is sufficient to conduct irradiations 
achieving clinically useful BNCT target tissue dose 
levels in times of 30 minutes or less.  The lithium 
shielding should reduce whole-body boron and 
nitrogen capture doses to acceptable levels.
     Efforts are ongoing to characterize the incident 
gamma field within the enclosure and to develop 
appropriate procedures for management of tritium 
produced in the shield enclosure.   This will be 
followed by normal-tissue radiation tolerance 
measurements and, ultimately, various small-animal 
BNCT radiobiological research studies. 
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